Get startedLog in
    Picture of Corcept Therapeutics Incorporated logo

    CORT — Corcept Therapeutics Incorporated News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousLarge CapHigh Flyer
    All News

    Brief: Corcept Therapeutics Q3 EPS USD 0.41 Vs. IBES Estimate USD 0.28

    Picture of Corcept Therapeutics Incorporated logoCorcept Therapeutics Incorporated
    30/10/2024 20:05
    Oct 30 (Reuters) - Corcept Therapeutics Q3 revenue USD 182.546 million vs.
IBES estimate USD 172 million.
* Q3 net income USD 47.213 million vs. IBES estimate USD 32.4 million
* Q3 cash & investments USD 547.6 million
* outlook FY revenue USD 675-700 million

    Recent news on Corcept Therapeutics Incorporated

    See all news